Apotex and Strides to merge their Australia businesses by Eric Palmer Monday, May 14, 2018 Canada-based Apotex has agreed to merge its Australian business with that of India’s Strides Shasun.
Grocers take on generic drug industry in price-fixing suit by Eric Sagonowsky Wednesday, January 31, 2018 Kroger and other grocery chains are suing Mylan, Teva, Endo and many other companies for an "overarching conspiracy" to artificially inflate prices.
Apotex CEO Jeremy Desai resigns in midst of turmoil by Eric Palmer Monday, January 29, 2018 Apotex CEO Jeremy Desai has resigned even as the company deals with the fallout from the murders of the company’s founder and his wife.
FiercePharmaAsia—Nanjing Legend, Eisai-Biogen, Impax and more by Angus Liu Friday, January 5, 2018 Legend teams with J&J on CAR-T project, Eisai and Biogen's Alzheimer's drug fails in early readout, Impax and Bora Pharma ink deal.
U.K. cites Apotex plant in India over cross-contamination issues by Eric Palmer Wednesday, January 3, 2018 U.K. authorities have cited an Apotex plant in India. The action comes even as Canadian police are probing the strangulation of the Apotex chairman.
Teva sues former exec for siphoning trade secrets to boyfriend by Arlene Weintraub Tuesday, July 11, 2017 Israel’s Teva is suing a former U.S. employee over allegations she shared company secrets with her boyfriend, the CEO of rival Apotex.
Roche recalls Valium in Australia after tampering uncovered by Eric Palmer Thursday, June 1, 2017 Roche has recalled all of its 5-mg Valium blister packs in Australia after uncovering a supply chain breach at a distributor's warehouse.
Lilly's ADHD med Strattera faces generic stampede by Eric Sagonowsky Wednesday, May 31, 2017 Eli Lilly’s $500 million-plus ADHD med Strattera succumbed to generics Tuesday as four drugmakers won FDA green lights for their copycat.
